The Latest Breaking News from Aetna

A lawyer for ex-Ontrak CEO and executive chairman Terren Peizer called the case a “true miscarriage of justice from the get-go.”

It's usually challenging for patients to get out of Medicare Advantage. It can be easier if hospitals leave, first.

Wegovy and Ozempic are weight loss drugs that promise to transform the treatment of obesity, heart disease and other chronic conditions that afflict millions of Americans. But while everyone agrees these drugs have the potential to transform lives, no one can agree on how best to pay for them.

Employees should be free to choose their own health care plans, but be given the same contributions from their workplaces, Mark Bertolini argued.

Curbing agents’ commissions may hurt beneficiaries.

CVS and Walgreens shares have plummeted from all the M&A, while Rite Aid is a much smaller chain.

CVS CEO Karen Lynch lost her job in a surprise ouster on Friday.

The company's approach to guidance this year led to continual cutting of goals.

An activist shareholder demanding changes, soaring medical costs, and a $68 billion deal for Aetna.